Article
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
7 Feb 2024
Abstract excerpt
Decades of pharmacogenetic research have revealed genetic biomarkers of clinical response to antipsychotics. Genetic variants in antipsychotic targets, dopamine and serotonin receptors in particular, and in metabolic enzymes have been associated with the efficacy and toxicity of antipsychotic treatments. However, genetic prediction of antipsychotic response based on these biomarkers is far from accurate. Despite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
